MacroGenics
MGNX
#9145
Rank
A$0.17 B
Marketcap
A$2.74
Share price
2.23%
Change (1 day)
-47.05%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): A-$0.20

According to MacroGenics's latest financial reports the company's current EPS (TTM) is A-$0.07474. In 2024 the company made an earnings per share (EPS) of A-$1.60 a decrease over its 2023 EPS that were of A-$0.22.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.20-87.62%
2024A-$1.60613.33%
2023A-$0.22-92.31%
2022A-$2.92-42.14%
2021A-$5.0436.44%
2020A-$3.69-21.84%
2019A-$4.72-24.58%
2018A-$6.26675.93%
2017A-$0.81-68.05%
2016A-$2.53168.25%
2015A-$0.94-55%
2014A-$2.093400%
2013A-$0.05980-108.68%
2012A$0.6924.49%
2011A$0.55

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Xencor
XNCR
A-$2.65 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$2.57-3,540.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$11.35-15,287.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$9.75-13,140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$19.48-26,160.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$30.67-41,136.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.44-6,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA